EV/EBITDA:
-11.19-0.02(-0.18%)Summary
- As of today, AKRO EV/EBITDA is -11.19, with a fall of -0.02 (-0.18%) during the most recent trading session on October 16, 2025.
- Over the past year, AKRO EV/EBITDA has dropped by -5.75 (-105.70%).
- AKRO EV/EBITDA is now -1353.25% below its all-time high of -0.77.
Performance
AKRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -0.2% | +0.1% | +0.1% |
| 1M1 Month | -34.8% | +34.8% | +27.2% |
| 3M3 Months | +1.1% | -1.1% | -1.2% |
| 6M6 Months | -45.9% | +53.1% | +42.6% |
| YTDYTD | -144.3% | +175.2% | +92.9% |
| 1Y1 Year | -105.7% | +145.6% | +74.1% |
| 5Y5 Years | -7.1% | +418.1% | +89.3% |
AKRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -8.30 | -34.8% | -11.29 | +0.9% |
| 3M | 3-Month | -8.30 | -34.8% | -11.31 | +1.1% |
| 6M | 6-Month | -7.62 | -46.9% | -12.52 | +10.6% |
| 1Y | 1-Year | -3.07 | -264.5% | -12.90 | +13.3% |
| 3Y | 3-Year | -0.77 | -1353.3% | -24.06 | +53.5% |
| 5Y | 5-Year | -0.77 | -1353.3% | -24.06 | +53.5% |
| All-Time | All-Time | -0.77 | -1353.3% | -38.76 | +71.1% |
AKRO EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -11.19(-144.3%) |
| 2024 | -4.58(-1.8%) |
| 2023 | -4.50(+76.8%) |
| Date | Value |
|---|---|
| 2022 | -19.39(-253.8%) |
| 2021 | -5.48(+30.5%) |
| 2020 | -7.88(+27.8%) |
| 2019 | -10.91 |
FAQ
- What is Akero Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Akero Therapeutics, Inc.?
- What is AKRO EV/EBITDA year-to-date change?
- What is Akero Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Akero Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of AKRO is -11.19
What is the all-time high EV/EBITDA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high EV/EBITDA is -0.77
What is AKRO EV/EBITDA year-to-date change?
Akero Therapeutics, Inc. EV/EBITDA has changed by -6.61 (-144.32%) since the beginning of the year
What is Akero Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, AKRO EV/EBITDA has changed by -5.75 (-105.70%)